Tela Historical Balance Sheet

TELA Stock

USD 1.97 0.01 0.51%

Trend analysis of Tela Bio balance sheet accounts such as Total Stockholder Equity of 29.9 M, Other Liab of 324.9 K, Net Tangible Assets of 14.3 M or Property Plant And Equipment Net of 2.1 M provides information on Tela Bio's total assets, liabilities, and equity, which is the actual value of Tela Bio to its prevalent stockholders. By breaking down trends over time using Tela Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Tela Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tela Bio is a good buy for the upcoming year.

Tela Bio Inventory

8.26 Million

Build AI portfolio with Tela Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.

About Tela Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Tela Bio at a specified time, usually calculated after every quarter, six months, or one year. Tela Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tela Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tela currently owns. An asset can also be divided into two categories, current and non-current.

Tela Bio Balance Sheet Chart

At present, Tela Bio's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 14.3 M, whereas Total Assets are forecasted to decline to about 67.7 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Tela Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tela Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Tela Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tela Bio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Tela Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Tela Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tela Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.At present, Tela Bio's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 14.3 M, whereas Total Assets are forecasted to decline to about 67.7 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	40.3M	41.1M	41.7M	34.6M
Total Assets	67.9M	78.0M	86.6M	67.7M

Short Long Term Debt Total Total Assets

Tela Bio balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.93	0.82	0.72	0.97	-0.97	0.96	0.55	-0.39	-0.48	-0.85	0.11	0.97	0.86	-0.29	-0.39	0.93	0.97	0.83	0.87	0.92	-0.93	0.82	0.78	0.97	-0.91
Short Long Term Debt Total	0.93		0.89	0.84	0.84	-0.95	0.83	0.61	-0.39	-0.15	-0.88	0.34	0.85	0.93	-0.16	-0.39	1.0	0.85	0.86	0.85	0.99	-0.78	0.9	0.66	0.92	-0.75
Other Current Liab	0.82	0.89		0.97	0.71	-0.76	0.69	0.88	-0.46	-0.03	-0.92	0.16	0.7	0.97	0.08	-0.46	0.87	0.66	0.98	0.97	0.89	-0.66	0.97	0.43	0.9	-0.61
Total Current Liabilities	0.72	0.84	0.97		0.62	-0.7	0.59	0.9	-0.42	0.14	-0.89	0.21	0.57	0.93	0.13	-0.42	0.83	0.54	0.96	0.91	0.84	-0.57	0.97	0.34	0.83	-0.52
Total Stockholder Equity	0.97	0.84	0.71	0.62		-0.95	1.0	0.48	-0.41	-0.57	-0.82	0.03	0.95	0.74	-0.42	-0.41	0.84	0.96	0.76	0.8	0.82	-0.99	0.75	0.85	0.94	-0.98
Other Liab	-0.97	-0.95	-0.76	-0.7	-0.95		-0.94	-0.46	0.39	0.36	0.83	-0.3	-0.92	-0.83	0.33	0.39	-0.95	-0.94	-0.77	-0.79	-0.94	0.91	-0.8	-0.83	-0.93	0.89
Net Tangible Assets	0.96	0.83	0.69	0.59	1.0	-0.94		0.45	-0.36	-0.59	-0.79	0.02	0.95	0.71	-0.46	-0.36	0.83	0.96	0.74	0.78	0.81	-0.99	0.73	0.87	0.93	-0.99
Property Plant And Equipment Net	0.55	0.61	0.88	0.9	0.48	-0.46	0.45		-0.39	0.14	-0.78	-0.05	0.39	0.8	0.16	-0.39	0.59	0.35	0.91	0.87	0.61	-0.46	0.87	0.07	0.71	-0.4
Current Deferred Revenue	-0.39	-0.39	-0.46	-0.42	-0.41	0.39	-0.36	-0.39		0.08	0.7	-0.01	-0.34	-0.49	-0.47	1.0	-0.39	-0.34	-0.43	-0.49	-0.36	0.32	-0.4	-0.21	-0.41	0.31
Net Debt	-0.48	-0.15	-0.03	0.14	-0.57	0.36	-0.59	0.14	0.08		0.16	0.5	-0.65	-0.03	0.42	0.08	-0.16	-0.64	-0.07	-0.2	-0.15	0.58	0.02	-0.57	-0.36	0.62
Retained Earnings	-0.85	-0.88	-0.92	-0.89	-0.82	0.83	-0.79	-0.78	0.7	0.16		-0.08	-0.76	-0.91	-0.05	0.7	-0.87	-0.74	-0.92	-0.92	-0.85	0.76	-0.92	-0.54	-0.91	0.73
Accounts Payable	0.11	0.34	0.16	0.21	0.03	-0.3	0.02	-0.05	-0.01	0.5	-0.08		0.01	0.31	0.15	-0.01	0.35	0.06	0.11	0.09	0.37	0.0	0.18	0.22	0.09	0.02
Cash	0.97	0.85	0.7	0.57	0.95	-0.92	0.95	0.39	-0.34	-0.65	-0.76	0.01		0.73	-0.35	-0.34	0.85	0.99	0.7	0.76	0.85	-0.91	0.68	0.82	0.9	-0.9
Non Current Assets Total	0.86	0.93	0.97	0.93	0.74	-0.83	0.71	0.8	-0.49	-0.03	-0.91	0.31	0.73		0.07	-0.49	0.92	0.72	0.95	0.94	0.94	-0.68	0.95	0.47	0.9	-0.63
Non Currrent Assets Other	-0.29	-0.16	0.08	0.13	-0.42	0.33	-0.46	0.16	-0.47	0.42	-0.05	0.15	-0.35	0.07		-0.47	-0.17	-0.37	-0.02	0.0	-0.15	0.52	-0.08	-0.51	-0.26	0.54
Other Assets	-0.39	-0.39	-0.46	-0.42	-0.41	0.39	-0.36	-0.39	1.0	0.08	0.7	-0.01	-0.34	-0.49	-0.47		-0.39	-0.34	-0.43	-0.49	-0.36	0.32	-0.4	-0.21	-0.41	0.31
Long Term Debt	0.93	1.0	0.87	0.83	0.84	-0.95	0.83	0.59	-0.39	-0.16	-0.87	0.35	0.85	0.92	-0.17	-0.39		0.85	0.85	0.84	0.99	-0.78	0.89	0.67	0.91	-0.75
Cash And Short Term Investments	0.97	0.85	0.66	0.54	0.96	-0.94	0.96	0.35	-0.34	-0.64	-0.74	0.06	0.99	0.72	-0.37	-0.34	0.85		0.68	0.74	0.84	-0.92	0.66	0.84	0.89	-0.92
Net Receivables	0.83	0.86	0.98	0.96	0.76	-0.77	0.74	0.91	-0.43	-0.07	-0.92	0.11	0.7	0.95	-0.02	-0.43	0.85	0.68		0.98	0.86	-0.73	0.98	0.45	0.93	-0.68
Common Stock Shares Outstanding	0.87	0.85	0.97	0.91	0.8	-0.79	0.78	0.87	-0.49	-0.2	-0.92	0.09	0.76	0.94	0.0	-0.49	0.84	0.74	0.98		0.85	-0.77	0.94	0.52	0.95	-0.73
Long Term Debt Total	0.92	0.99	0.89	0.84	0.82	-0.94	0.81	0.61	-0.36	-0.15	-0.85	0.37	0.85	0.94	-0.15	-0.36	0.99	0.84	0.86	0.85		-0.76	0.9	0.65	0.91	-0.73
Non Current Liabilities Total	-0.93	-0.78	-0.66	-0.57	-0.99	0.91	-0.99	-0.46	0.32	0.58	0.76	0.0	-0.91	-0.68	0.52	0.32	-0.78	-0.92	-0.73	-0.77	-0.76		-0.72	-0.87	-0.92	1.0
Inventory	0.82	0.9	0.97	0.97	0.75	-0.8	0.73	0.87	-0.4	0.02	-0.92	0.18	0.68	0.95	-0.08	-0.4	0.89	0.66	0.98	0.94	0.9	-0.72		0.47	0.92	-0.67
Other Current Assets	0.78	0.66	0.43	0.34	0.85	-0.83	0.87	0.07	-0.21	-0.57	-0.54	0.22	0.82	0.47	-0.51	-0.21	0.67	0.84	0.45	0.52	0.65	-0.87	0.47		0.72	-0.88
Other Stockholder Equity	0.97	0.92	0.9	0.83	0.94	-0.93	0.93	0.71	-0.41	-0.36	-0.91	0.09	0.9	0.9	-0.26	-0.41	0.91	0.89	0.93	0.95	0.91	-0.92	0.92	0.72		-0.89
Total Liab	-0.91	-0.75	-0.61	-0.52	-0.98	0.89	-0.99	-0.4	0.31	0.62	0.73	0.02	-0.9	-0.63	0.54	0.31	-0.75	-0.92	-0.68	-0.73	-0.73	1.0	-0.67	-0.88	-0.89

Click cells to compare fundamentals

Tela Bio Account Relationship Matchups

Tela Bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	86.5M	62.5M	67.9M	78.0M	86.6M	67.7M
Short Long Term Debt Total	30.8M	31.5M	40.3M	41.1M	41.7M	34.6M
Other Current Liab	6.0M	8.2M	10.5M	14.7M	16.9M	9.4M
Total Current Liabilities	6.6M	10.6M	12.4M	17.0M	15.6M	11.6M
Total Stockholder Equity	49.0M	20.1M	14.3M	18.9M	28.5M	29.9M
Net Tangible Assets	28.1M	46.4M	17.8M	11.8M	13.6M	14.3M
Property Plant And Equipment Net	626K	1.2M	2.9M	3.9M	4.1M	2.1M
Net Debt	(43.6M)	(12.4M)	(2.1M)	(5.6M)	(11.0M)	(11.6M)
Retained Earnings	(196.7M)	(229.9M)	(274.2M)	(320.9M)	(358.7M)	(376.7M)
Accounts Payable	652K	2.4M	1.5M	1.7M	2.1M	1.7M
Cash	74.4M	43.9M	42.0M	46.7M	52.7M	45.9M
Non Current Assets Total	3.2M	3.5M	5.4M	6.3M	8.5M	4.9M
Non Currrent Assets Other	(3.2M)	(3.5M)	(5.4M)	265K	2.5M	2.7M
Long Term Debt	30.8M	31.5M	39.9M	40.5M	41.1M	34.0M
Cash And Short Term Investments	74.4M	43.9M	42.0M	46.7M	52.7M	47.2M
Net Receivables	2.7M	4.2M	6.6M	9.7M	10.1M	5.3M
Common Stock Shares Outstanding	12.9M	14.5M	16.3M	22.9M	28.5M	16.4M
Long Term Debt Total	31.4M	30.2M	31.5M	39.9M	45.9M	30.4M
Liabilities And Stockholders Equity	86.5M	62.5M	67.9M	78.0M	86.6M	67.7M
Non Current Liabilities Total	30.8M	31.9M	41.1M	42.2M	42.5M	49.2M
Inventory	3.9M	7.7M	11.8M	13.2M	12.8M	8.3M
Other Current Assets	4.5M	6.5M	2.0M	2.1M	2.5M	3.2M
Other Stockholder Equity	245.7M	250.1M	288.4M	339.7M	387.1M	235.9M
Total Liab	37.4M	42.4M	53.6M	59.2M	58.1M	57.6M
Net Invested Capital	79.9M	51.6M	54.2M	59.4M	69.6M	73.1M
Property Plant And Equipment Gross	626K	4.9M	2.9M	8.3M	8.7M	9.2M
Total Current Assets	83.2M	59.1M	62.4M	71.7M	78.1M	62.8M
Accumulated Other Comprehensive Income	(71K)	(52K)	150K	91K	90K	94.5K
Net Working Capital	76.6M	48.5M	50.0M	54.8M	62.5M	51.1M
Common Stock	14K	15K	19K	24K	39K	41.0K
Property Plant Equipment	677K	626K	1.2M	1.7M	1.9M	1.1M
Capital Stock	14K	15K	19K	24K	39K	41.0K
Intangible Assets	2.6M	2.3M	2.5M	2.1M	1.7M	2.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A

When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:

How To Invest In Tela

Details

Is Tela Stock a good investment?

Details

What is Tela Bio's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.

You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.35)

Revenue Per Share

2.113

Quarterly Revenue Growth

0.115

Return On Assets

(0.33)

Return On Equity

(2.67)

The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Tela Historical Balance Sheet

Tela Bio Inventory

8.26 Million

About Tela Balance Sheet Analysis

Tela Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Tela Bio balance sheet Correlations

Tela Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tela Bio balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Other Assets	+ 1.0	Current Deferred Revenue
Total Liab	+ 1.0	Non Current Liabilities Total
Long Term Debt Total	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.99	Cash

Total Liab	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Total Liab	- 0.98	Total Stockholder Equity
Other Liab	- 0.97	Total Assets
Long Term Debt	- 0.95	Other Liab